Transdermal Cannabinoids
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
25
NCT06738732
CBD Delivery with the A-Synaptic GT4 Transdermal Delivery System in with Dravet Syndrome And/or Lennox-Gastaut Syndrome
Phase: Phase 1/2
Role: Collaborator
Start: Jan 31, 2025
Completion: Jan 31, 2027
Loading map...